Pathogenic mutations in ARX, CDKL5 and STXBP1 genes are not associated with the early-onset epileptic encephalopathy in Malaysian pediatric patients: A pilot study

  • Ameerah Jaafar Department of Paediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
  • Feizel Alsiddiq Department of Paediatrics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
  • King Hwa Ling Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia.
Keywords: Early-onset epileptic encephalopathy, ARX gene, CDKL5 gene, STXBP1 gene, mutation screening, high resolution melting analysis, pediatric epilepsy

Abstract

Gene mutation is one of the etiologies of early-onset epileptic encephalopathy (EOEE), an age-dependent seizure in infants, which leads to brain defects. Previous studies have shown that several genes namely, aristaless related homeobox (ARX), cyclin dependent kinase like 5 (CDKL5) and syntaxin binding protein 1 (STXBP1) are responsible for the pathophysiology of the syndrome. The study involved 20 EOEE patients and 60 control subjects, which aimed to investigate the clinical association of Malaysian EOEE subjects with 13 known pathogenic mutations in the genes of interest. In addition, the entire ARX exonic region was also sequenced for known and novel mutations. PCR specificity and efficiency were optimized using conventional PCR and High Resolution Melting Analysis (HRMA). All cases and approximately 10% of control amplicon samples were purified and subjected to DNA sequencing. All known mutations reported previously were not found in control subjects and Malaysian EOEE patients with 100% confirmation by sequencing results. Sequencing of ARX exonic regions of patient samples did not find any mutation in all exons. The preliminary study indicates that selected known pathogenic mutations of ARX, CDKL5 and STXBP1 are not associated with EOEE in Malaysian paediatric patients.

References

Archer HL, Evans J, Edwards S, Colley J, Newbury-Ecob R, O'Callaghan F, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet. 2006;43(9):729-734. https://doi.org/10.1136/jmg.2006.041467

Bahi-Buisson N, Bienvenu T. CDKL5-Related Disorders: From Clinical Description to Molecular Genetics. Mol Syndromol. 2012;2(3-5):137-152. https://doi.org/10.1159/000331333

Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, Girard B, et al. Key clinical features to identify girls with CDKL5 mutations. Brain. 2008;131(Pt 10):2647-2661. https://doi.org/10.1093/brain/awn197

Buoni S, Zannolli R, Colamaria V, Macucci F, di Bartolo RM, Corbini L, et al. Myoclonic encephalopathy in the CDKL5 gene mutation. Clin Neurophysiol. 2006;117(1):223-227. https://doi.org/10.1016/j.clinph.2005.09.008

Castrén M, Gaily E, Tengström C, Lähdetie J, Archer H, Ala-Mello S. Epilepsy caused by CDKL5 mutations. Eur J Paediatr Neurol. 2011;15(1):65-69. https://doi.org/10.1016/j.ejpn.2010.04.005

Evans JC, Archer HL, Colley JP, Ravn K, Nielsen JB, Kerr A, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet. 2005;13(10):1113-1120. https://doi.org/10.1038/sj.ejhg.5201451

Friocourt G, Poirier K, Rakić S, Parnavelas JG, Chelly J. The role of ARX in cortical development. Eur J Neurosci. 2006;23(4):869-876. https://doi.org/10.1111/j.1460-9568.2006.04629.x

Fullston T, Brueton L, Willis T, Philip S, MacPherson L, Finnis M, et al. Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C>G/p.Y27X). Eur J Hum Genet. 2010;18(2):157-162. https://doi.org/10.1038/ejhg.2009.139

Intusoma U, Hayeeduereh F, Plong-On O, Sripo T, Vasiknanonte P, Janjindamai S, et al. Mutation screening of the CDKL5 gene in cryptogenic infantile intractable epilepsy and review of clinical sensitivity. Eur J Paediatr Neurol. 2011;15(5):432-438. https://doi.org/10.1016/j.ejpn.2011.01.005

Kamien BA, Cardamone M, Lawson JA, Sachdev R. A genetic diagnostic approach to infantile epileptic encephalopathies. J Clin Neurosci. 2012;19(7):934-941. https://doi.org/10.1016/j.jocn.2012.01.017

Liang J-S, Shimojima K, Takayama R, Natsume J, Shichiji M, Hirasawa K, et al. CDKL5 alterations lead to early epileptic encephalopathy in both genders. Epilepsia. 2011;52(10):1835-1842. https://doi.org/10.1111/j.1528-1167.2011.03174.x

Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet. 2005;14(14):1935-1946. https://doi.org/10.1093/hmg/ddi198

Mignot C, Moutard M-L, Trouillard O, Gourfinkel-An I, Jacquette A, Arveiler B, et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia. 2011;52(10):1820-1827. https://doi.org/10.1111/j.1528-1167.2011.03163.x

Nemos C, Lambert L, Giuliano F, Doray B, Roubertie A, Goldenberg A, et al. Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature. Clin Genet. 2009;76(4):357-371. https://doi.org/10.1111/j.1399-0004.2009.01194.x

Ohtahara S, Yamatogi Y. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006;70 Suppl 1:S58-S67. https://doi.org/10.1016/j.eplepsyres.2005.11.021

Panayiotopoulos CP. Neonatal epileptic seizures and neonatal epileptic syndromes. In: A Clinical Guide to Epileptic Syndromes and their Treatment. London: Springer London; 2010. pp. 237-258. https://doi.org/10.1007/978-1-84628-644-5_8

Rademacher N, Hambrock M, Fischer U, Moser B, Ceulemans B, Lieb W, et al. Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features. Neurogenetics. 2011;12(2):165-167. https://doi.org/10.1007/s10048-011-0277-6

Ricciardi S, Kilstrup-Nielsen C, Bienvenu T, Jacquette A, Landsberger N, Broccoli V. CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. Hum Mol Genet. 2009;18(23):4590-4602. https://doi.org/10.1093/hmg/ddp426

Rosas-Vargas H, Bahi-Buisson N, Philippe C, Nectoux J, Girard B, N'Guyen Morel MA, et al. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. J Med Genet. 2008;45(3):172-178. https://doi.org/10.1136/jmg.2007.053504

Russo S, Marchi M, Cogliati F, Bonati MT, Pintaudi M, Veneselli E, et al. Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics. 2009;10(3):241-250. https://doi.org/10.1007/s10048-009-0177-1

Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, Tohyama J, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40(6):782-788. https://doi.org/10.1038/ng.150

Saitsu H, Kato M, Okada I, Orii KE, Higuchi T, Hoshino H, et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. Epilepsia. 2010;51(12):2397-2405. https://doi.org/10.1111/j.1528-1167.2010.02728.x

Saletti V, Canafoglia L, Cambiaso P, Russo S, Marchi M, Riva D. A CDKL5 mutated child with precocious puberty. Am J Med Genet A. 2009;149A(5):1046-1051. https://doi.org/10.1002/ajmg.a.32806

Sampaio M, Rocha R, Biskup S, Leão M. Novel STXBP1 mutations in 2 patients with early infantile epileptic encephalopathy. J Child Neurol. 2015;30(5):622-624. https://doi.org/10.1177/0883073813479169

Suri M. The phenotypic spectrum of ARX mutations. Dev Med Child Neurol. 2005;47(2):133-137. https://doi.org/10.1111/j.1469-8749.2005.tb01102.x

Swanson DA, Steel JM, Valle D. Identification and Characterization of the Human Ortholog of Rat STXBP1, a Protein Implicated in Vesicle Trafficking and Neurotransmitter Release. Genomics. 1998;48(3):373-376. https://doi.org/10.1006/geno.1997.5202

Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004;75(6):1149-1154. https://doi.org/10.1086/426460

Thambyayah M. Early epileptic encephalopathies including West syndrome: a 3-year retrospective study from Klang Hospital, Malaysia. Brain Dev. 2001;23(7):603-604. https://doi.org/10.1016/S0387-7604(01)00293-5

Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OLD, Archer H, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75(6):1079-1093. https://doi.org/10.1086/426462

Published
2018-12-14
How to Cite
Jaafar, A., Alsiddiq, F. and Ling, K. H. (2018) “Pathogenic mutations in ARX, CDKL5 and STXBP1 genes are not associated with the early-onset epileptic encephalopathy in Malaysian pediatric patients: A pilot study”, Neuroscience Research Notes, 1(3), pp. 5-17. doi: 10.31117/neuroscirn.v1i3.16.